Patient‐reported disease control versus overall symptom severity as global metrics of chronic rhinosinusitis disease status
Open Access
- 13 September 2024
- journal article
- research article
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 15 (1) , 27-35
Abstract
Background: Overall symptom severity (OSS) and patient‐reported chronic rhinosinusitis (CRS) control are global measures of CRS identified as consensus, essential criteria for CRS disease control assessment. We sought to determine the functional relationship between these two metrics.Methods: Using an international multicenter mixed‐methods design, 260 CRS patients were recruited. OSS score was measured using a visual analog scale. Patient‐reported CRS control was measured as “controlled,” “partly controlled,” and “uncontrolled.” Twelve participants underwent semi‐structured interviews to discuss OSS and patient‐reported CRS control.Results: The majority of interviewed participants felt OSS and patient‐reported CRS control measured different constructs—while OSS only measured symptoms, patient‐reported CRS control was more global, including not only symptom severity but also concepts such as medication usage, activity impairment, and exacerbations. Nevertheless, OSS score was strongly correlated with (ρ = 0.67, p < 0.001) and highly predictive of patient‐reported CRS control. OSS score of >4 (95% confidence interval [CI]: 1.8–4.2) had 74.7% sensitivity and 93.2% specificity in identifying patients reporting their CRS as not controlled. OSS score of >6.6 (95% CI: 4.1–7.1) had 77.0% sensitivity and 75.9% specificity in identifying patients reporting their CRS as uncontrolled. The 22‐item Sinonasal Outcome Test score was also predictive of patient‐reported CRS disease control but OSS was significantly more predictive.Conclusions: Patients conceptually view patient‐reported CRS control as a more global measure that subsumes OSS. Quantitatively, however, OSS is highly correlated with patient‐reported CRS control, possibly reflecting their redundancy. For ease of use, we recommend patient‐reported CRS control be reflected by OSS <4 for controlled, 4 ≤ OSS < 7 for partly controlled, and OSS ≥7 for uncontrolled CRS.Keywords
This publication has 26 references indexed in Scilit:
- Chronic rhinosinusitis disease control: a review of the history and the evidenceExpert Review of Clinical Immunology, 2023
- Heterogeneity in the definition of chronic rhinosinusitis disease control: a systematic review of the scientific literatureEuropean Archives of Oto-Rhino-Laryngology, 2023
- Qualitative Research Methodology and Applications: A Primer for the OtolaryngologistThe Laryngoscope, 2023
- Determinants of physician assessment of chronic rhinosinusitis disease control using EPOS 2020 criteria and the importance of incorporating patient perspectives of disease controlInternational Forum of Allergy & Rhinology, 2023
- Defining ‘control’ of chronic rhinosinusitisCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2022
- Chronic rhinosinusitis control from the patient and physician perspectivesLaryngoscope Investigative Otolaryngology, 2018
- A contemporary analysis of clinical and demographic factors of chronic rhinosinusitis patients and their association with disease severityIrish Journal of Medical Science (1971 -), 2018
- The 22‐item Sino‐Nasal Outcome Test accurately reflects patient‐reported control of chronic rhinosinusitis symptomatologyInternational Forum of Allergy & Rhinology, 2017
- Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centreAllergy, 2016
- Modification of the lund‐kennedy endoscopic scoring system improves its reliability and correlation with patient‐reported outcome measuresThe Laryngoscope, 2014